Esperion Therapeutics (ESPR) Goodwill & Intangibles (2012 - 2026)
Esperion Therapeutics (ESPR) reported Goodwill & Intangibles of $56000.0 for Q1 2026, little changed on a YoY basis from $56000.0 in Q1 2025, and little changed quarter-over-quarter from $56000.0 in Q4 2025.
Esperion Therapeutics (ESPR) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Esperion Therapeutics has reported Goodwill & Intangibles for 15 years, with the latest figure at $56000.0 in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $56000.0; the trailing twelve-month figure through Mar 2026 stood at $56000.0 (changed 0.0% YoY), and the FY2025 full-year result was $56000.0, changed 0.0% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $56000.0, roughly flat from $56000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $56000.0 in Q1 2022, with the low at $56000.0 in Q1 2022.
- Historically, Goodwill & Intangibles has averaged $56000.0 across 5 years, with a median of $56000.0 in 2022.
- The largest YoY upside for Goodwill & Intangibles was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
- Esperion Therapeutics' Goodwill & Intangibles stood at $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then changed by 0.0% to $56000.0 in 2025, then changed by 0.0% to $56000.0 in 2026.
- The last three Goodwill & Intangibles figures came in at $56000.0 (Q1 2026), $56000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Esperion Therapeutics | 49.69 Mn | -118.16 Mn | 45.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 56,000.00 |
| Mar 31, 2025 | 56,000.00 |
| Dec 31, 2024 | 56,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 56,000.00 |
| Mar 31, 2023 | 56,000.00 |
| Dec 31, 2022 | 56,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 56,000.00 |